Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Remedium Lifecare

₹81 0.3 | 0.4%

Market Cap ₹816 Cr.

Stock P/E 10.8

P/B 9

Current Price ₹81

Book Value ₹ 9

Face Value 1

52W High ₹179.7

Dividend Yield 0%

52W Low ₹ 66.9

Remedium Lifecare Research see more...

Overview Inc. Year: 1988Industry: Trading

Remedium Lifecare Ltd is an Indian pharmaceutical company that specializes in manufacturing and marketing a wide range of high-quality generic medicines and healthcare products. The company was established in 1981 and is headquartered in Mumbai, with manufacturing facilities located in various parts of the country. Remedium Lifecare has a strong presence in both the domestic and international markets and exports its products to over 50 countries worldwide. The company's product portfolio includes antibiotics, antihypertensives, anti-diabetics, antifungals, cardiovascular drugs, and many more. Remedium Lifecare is committed to delivering affordable and accessible healthcare solutions to people across the globe and has received various certifications and accolades for its excellence in quality and innovation.

Read More..

Remedium Lifecare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Remedium Lifecare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 120 206 40 99 158 176 76 330 469 1834
Other Income 0 0 0 0 2 0 0 0 4 14
Total Income 120 206 40 99 160 177 76 330 473 1848
Total Expenditure 119 205 41 93 156 175 78 323 462 1779
Operating Profit 1 1 -1 7 4 2 -3 7 10 69
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 -2 0 0 0 0 0
Profit Before Tax 1 1 -1 6 2 2 -3 7 10 69
Provision for Tax 0 0 0 0 0 0 2 2 4 0
Profit After Tax 1 1 -1 6 2 2 -5 5 7 69
Adjustments -0 0 0 0 0 -0 0 -0 0 0
Profit After Adjustments 1 1 -1 6 2 2 -5 5 7 69
Adjusted Earnings Per Share 0.1 0.1 -0.1 0.6 0.2 0.2 -0.5 0.5 0.6 6.8

Remedium Lifecare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3 3 2 4 1 0 0 3 90 505 510 2709
Other Income 0 0 1 0 0 0 0 0 0 0 1 18
Total Income 3 3 3 4 1 0 0 3 90 505 511 2727
Total Expenditure 3 3 2 4 1 0 0 3 89 503 503 2642
Operating Profit 0 0 1 0 0 0 0 0 1 2 8 83
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 0 1 0 0 0 0 0 1 2 7 83
Provision for Tax 0 0 0 0 0 0 0 0 0 0 2 8
Profit After Tax -0 0 1 0 0 0 0 0 0 1 5 76
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 0 1 0 0 0 0 0 0 1 5 76
Adjusted Earnings Per Share -0 0 0.1 0 0 0 0 0 0 0.1 0.5 7.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 454% 0% 67%
Operating Profit CAGR 300% 0% 0% 0%
PAT CAGR 400% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -6% 200% 175% NA%
ROE Average 71% 36% 24% 13%
ROCE Average 103% 43% 28% 15%

Remedium Lifecare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 2 2 3 3 3 3 3 3 4 5 10
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 11 0 0
Other Non-Current Liabilities 0 0 -0 -0 0 -0 -0 0 0 0 -0
Total Current Liabilities 4 5 3 2 0 0 0 1 24 219 1144
Total Liabilities 6 7 6 5 3 3 4 4 39 224 1154
Fixed Assets 1 1 1 0 0 0 0 0 0 0 0
Other Non-Current Assets 1 1 1 1 1 1 0 0 0 0 0
Total Current Assets 4 5 3 4 2 2 4 4 38 224 1154
Total Assets 6 7 6 5 3 3 4 4 39 224 1154

Remedium Lifecare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 0 0 0 0 0 0 1 1 1 1
Cash Flow from Operating Activities -1 -0 0 -1 0 -0 -0 -0 -10 11 21
Cash Flow from Investing Activities 0 0 0 1 0 0 1 -0 -0 -0 -0
Cash Flow from Financing Activities -0 0 -0 -0 -0 -0 0 0 10 -11 -0
Net Cash Inflow / Outflow -0 0 -0 0 0 -0 1 -0 -0 1 20
Closing Cash & Cash Equivalent 0 0 0 0 0 0 1 1 1 1 22

Remedium Lifecare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0 0 0.06 0 0 0 0 0.03 0.05 0.11 0.54
CEPS(Rs) 0.01 0.01 0.06 0.01 0 0 0.01 0.03 0.05 0.11 0.55
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.24 0.24 0.3 0.3 0.3 0.3 0.31 0.33 0.38 0.49 1.03
Core EBITDA Margin(%) -6.16 0.03 -7.87 -7.59 -7.41 0.23 -43.18 13.42 0.8 0.36 1.41
EBIT Margin(%) -0.21 1.55 34.4 0.52 0.32 4.83 12.13 13.27 0.74 0.35 1.54
Pre Tax Margin(%) -0.25 1.51 34.37 0.28 0.3 4.77 12.07 12.97 0.73 0.3 1.45
PAT Margin (%) -0.25 0.98 27.68 0.28 0.25 3.88 5.03 9.58 0.53 0.21 1.06
Cash Profit Margin (%) 0.9 2.12 28.24 0.52 0.36 4.28 5.03 10.04 0.6 0.23 1.09
ROA(%) -0.11 0.38 8.92 0.21 0.09 0.42 0.24 7.11 2.25 0.82 0.79
ROE(%) -0.27 1.06 21.4 0.36 0.11 0.45 0.26 8.62 13.33 24.51 70.92
ROCE(%) -0.14 1.5 24.6 0.66 0.14 0.55 0.62 11.16 7.39 18.16 102.54
Receivable days 141.35 203.89 383.18 224.29 687.52 2189.19 2487.09 103.36 51.05 31.7 84.61
Inventory Days 257.33 264.8 279.87 100.49 0 0 469.61 57.2 7.72 31.45 32.64
Payable days 0 0 0 0 0 0 1426.41 80.6 50.25 54.31 77.15
PER(x) 0 0 0 0 0 0 695.95 28.98 32.97 46.26 48.94
Price/Book(x) 0 0 0 0 0 0 1.81 2.39 4.11 10.1 25.62
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.42 1.43 1.75 0.91 2.58 10.24 28.66 2.58 0.28 0.1 0.48
EV/Core EBITDA(x) 151.02 53.28 4.99 120.53 606.45 195.86 236.23 18.83 35.05 26.52 30.47
Net Sales Growth(%) -0.29 0.96 -19.38 85.64 -66.12 -73.72 -54.57 1716.59 3015.14 460.67 1
EBIT Growth(%) -122.45 858.81 1692.46 -97.2 -79.16 298 14.2 1886.53 74.33 162.1 347.82
PAT Growth(%) -135.6 499.98 2165.94 -98.13 -69.51 306.38 -41.18 3362.5 73.47 124.31 403.44
EPS Growth(%) -135.6 499.98 2165.98 -98.13 -69.49 306.21 -41.24 3365.97 73.47 124.31 403.44
Debt/Equity(x) 0.1 0.14 0.03 0 0 0 0.02 0.11 2.72 0 0
Current Ratio(x) 1.15 1.02 1.24 2.42 9.14 31.74 9.44 7.38 1.59 1.02 1.01
Quick Ratio(x) 0.61 0.59 0.74 1.88 12.86 31.74 8.89 6.1 1.46 0.64 1
Interest Cover(x) -4.82 41.13 1032.24 2.18 14.11 84.5 193 45.64 43.12 7.72 17.46
Total Debt/Mcap(x) 0 0 0 0 0 0 0.01 0.05 0.66 0 0

Remedium Lifecare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 1.11 1.11 1.11 1.11 1.11 1.11 1.11 1.11 1.11 1.11
FII 0 0 0 0 0 0 0.04 0.08 0.04 0.04
DII 0 0 0 0 0 0 0 0 0 0
Public 98.89 98.89 98.89 98.89 98.89 98.89 98.85 98.81 98.85 98.85
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 36%
  • Company is almost debt free.

Cons

  • Promoter holding is low: 1.11%.
  • Debtor days have increased from 54.31 to 77.15days.
  • Stock is trading at 9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Remedium Lifecare News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....